Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Horizon Discovery, acquired by PerkinElmer in 2020 and now operating under Revvity (as of May 2023), is a global leader in the application of gene editing and gene modulation technologies. They provide a comprehensive portfolio of tools, services, and research reagents—including CRISPR screening libraries, custom-engineered cell lines, and base editing technologies—to academic, drug discovery, and clinical research organizations. Horizon's expertise empowers scientists to understand the genetic drivers of disease, identify novel drug targets, and develop next-generation cell and gene therapies. Their offerings are integral to advancing precision medicine and biopharmaceutical development.
Serves as a major research and development hub, manufacturing site for gene editing tools and cell models, and a center of excellence for Revvity's life sciences division.
Located within the Cambridge Research Park, a prominent European biotechnology cluster. Features advanced laboratories for cell biology, molecular biology, and GMP-compliant cell line engineering.
As part of Revvity, the site fosters a culture of scientific innovation, collaboration, and precision, driven by a commitment to impacting human health. Emphasis on cutting-edge research and high-quality product development.
Its Cambridge location places it at the heart of a world-renowned life sciences ecosystem, facilitating academic and industry collaborations, talent acquisition, and innovation in gene editing technologies.
Through Revvity's extensive global infrastructure, Horizon Discovery's technologies, products, and services are available to researchers and clinicians worldwide. Revvity has a robust network for sales, distribution, technical support, and service across North America, Europe, Asia-Pacific, and other key international markets. This global reach ensures that scientists in academic institutions, pharmaceutical companies, biotech firms, and diagnostic labs have access to cutting-edge gene editing and modulation solutions.
8100 Cambridge Research Park, Waterbeach
Cambridge
Cambridgeshire
United Kingdom
Address: A Revvity facility in the Boulder/Lafayette area, integrating former Horizon Discovery and Dharmacon operations (e.g., 2650 Crescent Dr, Lafayette, CO 80026, USA).
Supports the North American market with advanced research tools and services, leveraging expertise from the legacy Dharmacon and Horizon Discovery businesses to drive innovation in genomics.
Address: A Revvity facility (e.g., 20271 Goldenrod Lane, Suite 2061, Germantown, MD 20876, a known previous site for Horizon's diagnostic reference standards). Address may vary post-integration.
Provides essential tools for the diagnostics industry, ensuring accuracy and reliability in molecular testing across the US and globally.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Horizon Discovery' leadership includes:
Horizon Discovery has been backed by several prominent investors over the years, including:
Following Horizon Discovery's acquisition by PerkinElmer (now Revvity) and its full integration, distinct executive movements for 'Horizon Discovery' as a standalone entity are no longer applicable. Leadership changes occur within Revvity's broader corporate structure. The most significant recent event was the rebranding of PerkinElmer's Life Sciences and Diagnostics businesses to Revvity in May 2023, solidifying the new leadership structure for the integrated entity.
Discover the tools Horizon Discovery uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition, Horizon Discovery likely used common corporate email formats such as [first_initial][last]@horizondiscovery.com or [first].[last]@horizondiscovery.com. Since integration into PerkinElmer and now Revvity, employees use Revvity's standard email format, which is typically [first].[last]@revvity.com.
Current: [first].[last]@revvity.com; Legacy: [first_initial][last]@horizondiscovery.com
Format
jane.doe@revvity.com
Example
85%
Success rate
Revvity Press Release • May 9, 2023
PerkinElmer, Inc. announced the launch of Revvity, a new science-first company formed from its divested Applied, Food and Enterprise Services businesses and its Life Sciences and Diagnostics businesses. Horizon Discovery's gene editing and modulation capabilities are now part of Revvity's offerings....more
Horizon Discovery Press Release (Archived) / PerkinElmer News • November 18, 2020
PerkinElmer, Inc. announced it had reached an agreement on the terms of a recommended all cash offer to acquire Horizon Discovery Group plc. The acquisition aimed to expand PerkinElmer's portfolio of leading life sciences solutions and enhance its cell engineering capabilities....more
Revvity Press Release • February 27, 2024
Revvity announced the launch of its Pin-Point™ base editing system, a next-generation modular gene editing platform leveraging technology initially developed by Horizon Discovery. This platform offers increased accuracy and efficiency for cell therapy research and development....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Horizon Discovery, are just a search away.